BIK/ NBK (phospho-T33) polyclonal Antibody | BS4215

BIK/ NBK (phospho-T33) polyclonal Antibody | BS4215 | Gentaur UK, US & Europe Distribution

Host: Rabbit

Reactivity: Human

Application: WB IHC

Application Range: WB: 1:500~1:1000 IHC: 1:50~1:200

Background: The Bcl-2 gene was isolated at the chromosomal breakpoint of t-bearing follicular B cell lymphomas. Bcl-2 blocks cell death following a variety of stimuli and confers a death-sparing effect to certain hematopoietic cell lines following growth factor withdrawal. A protein designated Bax p21 (i.e., Bcl-associated X protein) has extensive amino acid homology with Bcl-2 and both homodimerizes and heterodimerizes with Bcl-2. Overexpression of Bax accelerates apoptotic death. Natural born killer (NBK), also known as Bik, is a protein that is functionally related to Bax, although the two proteins share very little sequence homology. NBK does not contain the conserved Bcl-2 homology domains (BH domains) characteristic of the Bcl-2 family. It does however, share nine amino acids with Bax in a region designated BH3, which may be the critical determinant for the protein’s death-promoting activities. Phosphorylation of NBK at Ser35 and Thr33 is required for eliciting efficient apoptotic activity.

Storage & Stability: Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.

Specificity: p-NBK (T33) polyclonal Antibody detects endogenous levels of NBK protein only when phosphorylated at Thr33.

Molecular Weight: ~ 23 kDa

Note: For research use only, not for use in diagnostic procedure.

Alternative Names: Apoptosis inducer NBK; BBC1; Bcl-2-interacting killer; BCL2 interacting killer; bhikhari; BIK; Bik-like killer protein; BIK; BIP 1; BIP1; BP 4; BP4; cb 60; NBK;

Immunogen: Synthetic phosphopeptide derived from human BIK/ NBK around the phosphorylation site of Threonine 33.

Conjugate: N/A

Modification: N/A

Purification & Purity: The Antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen and the purity is > 95% (by SDS-PAGE) .

Pathway: N/A